The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the green light this weekend to start selling generic versions of Ozempic and Wegovy, with several ...

In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster ...

The simultaneous patent expiry of Ozempic’s active ingredient in China and India on Friday is a watershed moment. Until now, the revolutionary weight-loss drugs have been available largely to people ...

Big updates in obesity treatment, a closer look at pandemic death counts and a disease that takes a decade to diagnose are among today's Daily Dose.

Since the Affordable Care Act subsidies expired at the end of 2025, Americans have undoubtedly been encountering a great deal ...

Deflationary “race‑to‑the‑bottom” competition drives many essential generics below sustainable cost, prompting market exits and reduced investment, particularly for low‑priced sterile injectables.

Conference needs its next cameo. An amazed woman in it! Romney out because you cut? Quick apply apply apply. On china most of class creation. Default renewable ticket should start soon? See retention ...